Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration.
about
Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug deliveryPlacenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab InjectionAqueous vascular endothelial growth factor and aflibercept concentrations after bimonthly intravitreal injections of aflibercept for age-related macular degeneration.Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
P2860
Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Aqueous vascular endothelial g ...... -related macular degeneration.
@en
Aqueous vascular endothelial g ...... -related macular degeneration.
@nl
type
label
Aqueous vascular endothelial g ...... -related macular degeneration.
@en
Aqueous vascular endothelial g ...... -related macular degeneration.
@nl
prefLabel
Aqueous vascular endothelial g ...... -related macular degeneration.
@en
Aqueous vascular endothelial g ...... -related macular degeneration.
@nl
P2093
P2860
P1476
Aqueous vascular endothelial g ...... -related macular degeneration.
@en
P2093
Hajime Kawamura
Masahito Ohji
Masashi Kakinoki
Taichiro Miyake
Tomoko Sawada
Xiying Wang
Yoshitsugu Saishin
P2860
P2888
P304
P356
10.1007/S00417-013-2505-2
P577
2013-11-07T00:00:00Z